July 22 (Reuters) -
Kenneth Griffin:
* KENNETH GRIFFIN REPORTS 5.3% PASSIVE STAKE IN TERNS
PHARMACEUTICALS AS OF JULY 10 - SEC FILING
Source text for Eikon: